Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$55.06 - $69.99 $122,012 - $155,097
2,216 Added 196.28%
3,345 $187,000
Q4 2023

Feb 13, 2024

SELL
$57.25 - $69.74 $286,937 - $349,536
-5,012 Reduced 81.62%
1,129 $67,000
Q3 2023

Nov 14, 2023

SELL
$63.16 - $76.5 $578,735 - $700,969
-9,163 Reduced 59.87%
6,141 $412,000
Q2 2023

Aug 21, 2023

SELL
$46.28 - $75.01 $171,652 - $278,212
-3,709 Reduced 19.51%
15,304 $1.06 Million
Q1 2023

May 09, 2023

BUY
$43.42 - $57.37 $73,466 - $97,070
1,692 Added 9.77%
19,013 $916,000
Q4 2022

Feb 14, 2023

BUY
$38.8 - $55.46 $156,752 - $224,058
4,040 Added 30.42%
17,321 $864,000
Q2 2022

Aug 15, 2022

BUY
$33.54 - $55.0 $445,444 - $730,455
13,281 New
13,281 $730,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.13B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.